| Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST) JA De Souza, BJ Yap, K Wroblewski, V Blinder, FS Araújo, FJ Hlubocky, ... Cancer 123 (3), 476-484, 2017 | 677 | 2017 |
| Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST) JA De Souza, BJ Yap, K Wroblewski, V Blinder, FS Araújo, FJ Hlubocky, ... Cancer 123 (3), 476-484, 2017 | 677 | 2017 |
| Perceptions of cancer patients and their physicians involved in phase I trials. C Daugherty, MJ Ratain, E Grochowski, C Stocking, E Kodish, R Mick, ... Journal of Clinical Oncology 13 (5), 1062-1072, 1995 | 634 | 1995 |
| The development of a financial toxicity patient‐reported outcome in cancer: the COST measure JA De Souza, BJ Yap, FJ Hlubocky, K Wroblewski, MJ Ratain, D Cella, ... Cancer 120 (20), 3245-3253, 2014 | 536 | 2014 |
| ‘Hitting you over the head’: oncologists’ disclosure of prognosis to advanced cancer patients EJ Gordon, CK Daugherty Bioethics 17 (2), 142-168, 2003 | 322 | 2003 |
| American oncologists’ views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members PR Helft, F Hlubocky, CK Daugherty Journal of Clinical Oncology 21 (5), 942-947, 2003 | 230 | 2003 |
| Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer PC Nathan, CK Daugherty, KE Wroblewski, ML Kigin, TV Stewart, ... Journal of Cancer Survivorship 7 (3), 275-282, 2013 | 189 | 2013 |
| What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians’ self-reports of prognosis disclosure CK Daugherty, FJ Hlubocky Journal of Clinical Oncology 26 (36), 5988, 2008 | 180 | 2008 |
| General internists’ preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey E Suh, CK Daugherty, K Wroblewski, H Lee, ML Kigin, KA Rasinski, ... Annals of internal medicine 160 (1), 11-17, 2014 | 177 | 2014 |
| Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective CK Daugherty Journal of Clinical Oncology 17 (5), 1601-1601, 1999 | 168 | 1999 |
| Quantitative analysis of ethical issues in phase I trials: a survey interview study of 144 advanced cancer patients CK Daugherty, DM Banik, L Janish, MJ Ratain IRB: Ethics & Human Research 22 (3), 6-14, 2000 | 158 | 2000 |
| Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome AA Koen van Besien, S Smith, D Cao, S Rich, L Godley, D Jones, ... J Clin Oncol 23, 5728-5738, 2005 | 157 | 2005 |
| Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making FJ Hlubocky, MJ Ratain, M Wen, CK Daugherty Journal of Clinical Oncology 25 (5), 548-554, 2007 | 138 | 2007 |
| Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation AS Artz, DA Pollyea, M Kocherginsky, W Stock, E Rich, O Odenike, ... Biology of Blood and Marrow Transplantation 12 (9), 954-964, 2006 | 135 | 2006 |
| Use of the internet to obtain cancer information among cancer patients at an urban county hospital PR Helft, RE Eckles, CS Johnson-Calley, CK Daugherty Journal of Clinical Oncology 23 (22), 4954-4962, 2005 | 123 | 2005 |
| Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies MW Drazer, S Kadri, M Sukhanova, SA Patil, AH West, S Feurstein, ... Blood advances 2 (2), 146-150, 2018 | 109 | 2018 |
| How Often Do BRCA Mutation Carriers Tell Their Young Children of the Family's Risk for Cancer? A Study of Parental Disclosure of BRCA Mutations to Minors and … AR Bradbury, JJ Dignam, CN Ibe, SL Auh, FJ Hlubocky, SA Cummings, ... Journal of Clinical Oncology 25 (24), 3705-3711, 2007 | 106 | 2007 |
| Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists TO Henderson, FJ Hlubocky, KE Wroblewski, L Diller, CK Daugherty Journal of Clinical Oncology 28 (5), 878, 2010 | 105 | 2010 |
| Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation AK Siston, MA List, CK Daugherty, DM Banik, C Menke, K Cornetta, ... Bone marrow transplantation 27 (11), 1181-1188, 2001 | 104 | 2001 |
| Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation DA Pollyea, AS Artz, W Stock, C Daugherty, L Godley, OM Odenike, ... Bone marrow transplantation 40 (11), 1027-1032, 2007 | 93 | 2007 |
